Nontuberculous Mycobacteria clinical trials at UC Davis
1 research study open to eligible people
“Investigating the effects of a study treatment on symptom improvement in people with a new diagnosis of MAC lung infection”
open to eligible people ages 18 years and up
The primary objective of this study is to generate evidence demonstrating the domain specification via modern psychometric methods, reliability, validity, and responsiveness of Quality of Life - Bronchiectasis (QoL-B) and Patient-Reported Outcome Measurement Information System - Fatigue-Short Form (PROMIS F-SF 7a) in participants with newly diagnosed nontuberculous mycobacterial (NTM) lung infection caused by Myobaxterium avium Complex (MAC).
Santa Barbara, California and other locations